JAK Inhibitors Emerging as Oral Option for Psoriasis But older oral therapies remain key therapeutic players for many patients Oct 22, 2019
Chronic Itch: New Therapy, Complexities "End of the antihistamine era" as new strategies target neural mechanisms Oct 18, 2019
Finally, a Cure for the Common Cold... and Back Pain! The antidote to your Press-Ganey blues Oct 17, 2019
Unintentional Bias: It Can't Be Avoided but Can Be Overcome Simple techniques can improve hiring and help with inclusion Oct 16, 2019
Brain Injury After Concussion May Linger Some effects persist a year after college athletes return to play Oct 16, 2019
Joint Injections: Are They Worth the Risk? Adverse outcomes hastening joint replacement have raised concerns Oct 15, 2019
Parkinson's Risk Higher in People With Bipolar Disorder Analysis looks at more than 4 million people Oct 14, 2019
Conjugate Active in Exudative Retinal Diseases Improved vision, decreased retinal thickening with antibody-biopolymer agent Oct 13, 2019
Addressing Language Barriers How nurses can communicate with patients who speak limited English Oct 13, 2019
Deaf Parents Want Deaf Baby: Bioethicist Weighs In You voted, now see the results and an expert's discussion Oct 11, 2019
Excuse Me, Doctors and Nurses, Your Bias Is Showing "Prejudice" means to prejudge, and that's exactly what many of you do to patients Oct 10, 2019
Pop Star Sia Opens Up About Her Chronic Pain Hitmaker diagnosed with connective tissue disorder Oct 10, 2019
Mila's N-of-1 Trial Detailed in NEJM Neurologic scores stabilized, seizures diminished with tailored antisense oligonucleotide therapy Oct 09, 2019
CDC: Too Few Pregnant Women Getting Flu, Tdap Vax Room for improvement in clinician communication about vaccines in pregnancy Oct 08, 2019
Overweight Patients Less Likely to Gain Weight on Antipsychotic Analysis looked at users of brexpiprazole (Rexulti) Oct 07, 2019
Esketamine Nasal Spray Reduces Depression in Suicidal Patients Positive results from first global registration program of patients with active suicidal ideation, intent Oct 06, 2019
Novel Combo Tx Shows Durable Antipsychotic Effects Almost half of patients with schizophrenia deemed PANSS responders with samidorphan/olanzapine Oct 06, 2019
PM Stimulant Eases Daily Life for Kids With ADHD Parent-reported outcomes positive with delayed- and extended-release methylphenidate Oct 05, 2019
Injectable vs Oral Antipsychotics: Patients Have Preferences Long-acting injectables generally endorsed, but some still favor daily pills Oct 05, 2019
Can Anti-TNF Drugs Reduce Alzheimer's Risk? Analysis of 56 million patients hints at possible connections Oct 04, 2019
Ethics Consult: Deaf Couple Only Wants Deaf Baby You make the call: should doctor implant embryo selected for deafness? Oct 04, 2019
New Drug Alternative for Cushing's Syndrome? Levoketoconazole proved effective, but not clearly superior Oct 04, 2019
How Common Are Inaccurate Coronary Artery Calcium Scans? The Skeptical Cardiologist finds reason to suspect the MAC Oct 04, 2019
Does Zantac Break Down Into a Carcinogen? Rather than contamination, "the fundamental problem is that it's an unstable molecule" Oct 03, 2019
First-Line Combo Boosts PFS in Untreated Bladder Cancer 'Clinically meaningful' trend in OS with atezolizumab-chemotherapy Oct 03, 2019
Tennis Star Swings Back at Rheumatoid Arthritis Caroline Wozniacki hopes her nearly debilitating condition inspires others Oct 03, 2019
Pamrevlumab Appears Safe, Effective for IPF Findings "striking" but should be "treated with caution," expert warns Oct 01, 2019
NK3R Antagonist Promising for Vasomotor Symptoms in Menopause Appeared safe and effective, despite large placebo effect Sep 30, 2019
Benralizumab: A Second Chance in Patients With COPD? Findings are hypothesis-generating but "invaluable," one researcher says Sep 30, 2019
Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
Trametinib Tx Shows Promise in Tough-to-Treat LGSOC Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
Data Support 'Best Drug First' in EGFR-Mutant NSCLC Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
Cannabis for Symptomatic Menopause: Cultivating the Evidence Oyedeji Ayonrinde, FRCPsych, MBA, weeds out the known and unknown Sep 29, 2019
First-Line Combo Boosts PFS in Advanced Ovarian Ca Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
Heavy Drinking Among Middle-Aged Women: A Sobering Issue What can doctors do to better screen, treat this population? Sep 28, 2019
Advanced HCC Trial Misses OS Endpoint But CheckMate 459 researchers tout "encouraging efficacy and favorable safety profile" Sep 28, 2019
